Find Industry reports, Company profilesReportLinker ...
Find Industry reports, Company profilesReportLinker ...
Find Industry reports, Company profilesReportLinker ...
Find Industry reports, Company profilesReportLinker ...
Find Industry reports, Company profilesReportLinker ...
Find Industry reports, Company profilesReportLinker ...
Find Industry reports, Company profilesReportLinker ...
of 7

Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential

Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High PotentialSummaryGBI Research, the leading business intelligence provider, has released its latest report, 'Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential' that provides key data, information and analysis of the major trends and issues in Nanotechnology in Drug Delivery market. The report provides a comprehensive insight into the role of Nanotechnology in Drug Delivery. The report also provides a detailed analysis of market characterization of nanotechnology in drug delivery market in terms of its market size, segmentation by key geography types and the major market drivers and barriers. The report also talks about the technological trends over the years in use of nanotechnology in drug delivery.ScopeThe scope of the report includes - - Detailed overview of Nanotechnology in Drug Delivery in pharmaceutical industry along with their use, efficiency and limitation.- Annualized market data from 2007 and forecast forward till 2016 along with segmentation by geography. - Key market drivers and restraints shaping the Nanotechnology in Drug Delivery market.- Competitive landscape analysis with competitive profiling of leading companies.- Analysis of partnership deals from 2006 to 2010 - Analysis of M&A deals from 2005 to 2010 along with segmentation by value geography and companies.Reasons to buyThe report will enhance your decision making capability. It will allow you to - - Develop better strategies for Nanotechnology in Drug Delivery market by understanding the market dynamics.- Develop market-entry and market expansion strategies by identifying the key development area- Understand the factors shaping the Nanotechnology in Drug Delivery- For understanding the technological trends in the market.- Identify the key players best positioned to take the advantage of the opportunities in the global market.- Exploit partnership and acquisition opportunities by identifying the products that could fill the portfolio gaps.
Published on: Mar 3, 2016
Source: www.slideshare.net


Transcripts - Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential

  • 1. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!Nanotechnology in Drug Delivery - Technological Improvements andNovel Approaches to Fulfill High PotentialPublished on December 2010 Report SummaryNanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High PotentialSummaryGBI Research, the leading business intelligence provider, has released its latest report, Nanotechnology in Drug Delivery -Technological Improvements and Novel Approaches to Fulfill High Potential that provides key data, information and analysis of themajor trends and issues in Nanotechnology in Drug Delivery market. The report provides a comprehensive insight into the role ofNanotechnology in Drug Delivery. The report also provides a detailed analysis of market characterization of nanotechnology in drugdelivery market in terms of its market size, segmentation by key geography types and the major market drivers and barriers. Thereport also talks about the technological trends over the years in use of nanotechnology in drug delivery.ScopeThe scope of the report includes -- Detailed overview of Nanotechnology in Drug Delivery in pharmaceutical industry along with their use, efficiency and limitation.- Annualized market data from 2007 and forecast forward till 2016 along with segmentation by geography.- Key market drivers and restraints shaping the Nanotechnology in Drug Delivery market.- Competitive landscape analysis with competitive profiling of leading companies.- Analysis of partnership deals from 2006 to 2010- Analysis of M&A deals from 2005 to 2010 along with segmentation by value geography and companies.Reasons to buyThe report will enhance your decision making capability. It will allow you to -- Develop better strategies for Nanotechnology in Drug Delivery market by understanding the market dynamics.- Develop market-entry and market expansion strategies by identifying the key development area- Understand the factors shaping the Nanotechnology in Drug Delivery- For understanding the technological trends in the market.- Identify the key players best positioned to take the advantage of the opportunities in the global market.- Exploit partnership and acquisition opportunities by identifying the products that could fill the portfolio gaps. Table of ContentTable of Contents1 Table of Contents1 Table of Contents 3Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential (From Slideshare) Page 1/7
  • 2. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!1.1 List of Tables 61.2 List of Figures 62 Nanotechnology in Drug Delivery Introduction 72.1 Introduction 72.2 GBI Research Report Guidance 83 Application of Nanotechnology in Drug Delivery 93.1 Current Applications of Nano-enabled Drug Delivery 93.1.1 Nano-engineered drugs 93.1.2 Nano-carriers 103.2 Future Applications of Nano-enabled Drug Delivery 113.2.1 Gene and Vaccine Delivery 113.2.2 Controlled-Release Devices 123.2.3 Increased Biocompatibility 123.2.4 Improved Drug Bioavailability and Solubility 123.2.5 Applied Diagnosis, Etiology, Prognosis and Therapy (ADEPT) 123.2.6 Tissue Specific Delivery 124 Nanotechnology in Drug Delivery Case Studies 134.1 Abraxis Bioscience, Inc. Paclitaxel-Albumin Nanoparticles (Abraxane) 134.2 Nanospectra Biosciences AuroShell Particles 134.3 Calando Pharmaceuticals, Inc. RONDEL Technology 134.4 Starpharma Holdings, Ltd. Dendrimer-Based VivaGel 144.5 Mersana Therapeutics: Fleximer Camptothecin Conjugate 144.6 Elan Corporation NanoCrystal Technology 145 Nanotechnology in Drug Delivery Market Characterization 165.1 Introduction 165.2 Nano-enabled Drug Delivery Market Drivers 165.2.1 Clinical Benefits of Nano-enabled Drug delivery 165.2.2 Value Addition to Existing Pharmaceutical Products through Reformulation 165.2.3 Strong Pipeline Portfolio 165.3 Nano-Enabled Drug Delivery Market Barriers 175.3.1 Poor R&D Facilities and Time Gap between Research and Commercialization 175.3.2 Lack of Consistent Policy on Technology Transfer and Lack of Capacity to Produce Products 175.3.3 Regulatory Hindrance 175.4 Opportunity and Unmet Need Drug Delivery 185.4.1 Opportunities 185.4.2 Unmet Need 185.5 Selected Nano-Enabled Therapeutics Approved by the FDA 205.5.1 Doxil (Caelyx) 205.5.2 Abraxane 215.5.3 AmBisome 225.5.4 Diprivan 235.5.5 Triglide 245.5.6 Myocet 255.5.7 DepoCyt 265.5.8 DaunoXome 275.5.9 Estrasorb 275.5.10 Macugen 285.5.11 Abelcet 29Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential (From Slideshare) Page 2/7
  • 3. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!5.5.12 Adagen 305.5.13 Pegasys 305.5.14 Somavert 325.5.15 Neulasta 335.5.16 Copaxone 345.5.17 Amphotec 355.5.18 PegIntron 355.5.19 Oncaspar 375.5.20 Epaxal 385.5.21 Elestrin 386 Nanotechnology in Drug Delivery Trend Analysis 406.1 Increasing Government Funding for Nanotechnology R&D 406.2 Increasing Seed and Early-Stage Venture Capital 406.3 Creation of a New Registration Category for Nanotechnology Products within the USPTO 406.4 Genericization and Emerging Business Models Driving a Need for Novel Drug Delivery Methods 417 Nanotechnology in Drug Delivery Regulatory Landscape 427.1 Introduction 427.2 Europe 447.2.1 REACH Regulation 447.2.2 European Medicines Agency 467.3 The US 467.3.1 Environment Protection Agency 467.3.2 Food and Drug Administration 477.3.3 National Institute of Occupational Safety and Health 477.4 Japan 488 Nanotechnology in Drug Delivery Pipeline Analysis 498.1 Overview 498.1.1 Pipeline Analysis by Phase 509 Nanotechnology in Drug Delivery Strategic Consolidations 559.1 Overview 559.2 Mergers and Acquisitions 559.2.1 Mergers and Acquisitions by Geography 559.2.2 Mergers and Acquisitions by Deal value 569.2.3 Mergers and Acquisition Analysis by Deal Type 579.3 Summary of Major M&A Deals 589.3.1 AstraZeneca Acquires MedImmune 589.3.2 Pfizer Completes Acquisition of Wyeth 589.3.3 Celgene Announces To Acquire Abraxis BioScience 589.3.4 Amgen Acquires Abgenix 599.3.5 Teva Pharmaceutical Acquires Ivax 599.4 Licensing Agreement 609.4.1 Deals by Year of Consolidations 609.4.2 Deals by Geography 619.4.3 Deals by Deal value 629.5 Summary of Major M&A Deals 629.5.1 AstraZeneca Enters Into Collaboration and Licensing Agreement with Targacept 629.5.2 AstraZeneca Enters into Licensing Agreement with Rigel Pharmaceuticals 639.5.3 Isis Pharmaceuticals Enters Into Licensing Agreement with Genzyme 63Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential (From Slideshare) Page 3/7
  • 4. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!9.5.4 Nektar Therapeutics Enters Into Licensing Agreement with AstraZeneca 639.5.5 Abraxis Enters Into License Agreement With ProMetic Life Sciences 6410 Nanotechnology in Drug Delivery Future Players 6510.1 Overview 6510.2 Abraxis Bioscience (Abraxis) 6610.2.1 Overview 6610.2.2 Business Description 6610.2.3 Product Portfolio 6710.3 AlphaRx Corporation 6810.3.1 Overview 6810.3.2 Business Description 6810.3.3 Product Portfolio 6910.4 Camurus AB 6910.4.1 Overview 6910.4.2 Product Portfolio 7010.5 Eurand 7010.5.1 Overview 7010.5.2 Business Description 7010.5.3 Product Portfolio 7110.6 NanoBio Corporation 7110.6.1 Overview 7110.6.2 Product Portfolio 7210.7 NanoCarrier 7210.7.1 Overview 7210.7.2 Product Portfolio 7311 Nanaotechnology in Drug Delivery Appendix 7411.1 Market Definitions 7411.2 Abbreviations 7411.3 Research Methodology 7511.3.1 Coverage 7611.3.2 Secondary Research 7611.3.3 Primary Research 7611.3.4 Expert Panel Validation 7711.4 Contact Us 7711.5 Disclaimer 7711.6 Sources 77List of Tables1.1 List of TablesTable 1: Elan Pharmaceutical, Drugs Based on NanoCrystal Technology, 2010 15Table 2: Nanotechnology in Drug Delivery, Global, Regulatory Filing Clinical Pipeline, 2010 50Table 3: Nanotechnology in Drug Delivery, Global, Phase III Clinical Pipeline, 2010 51Table 4: Nanotechnology in Drug Delivery, Global, Phase II Clinical Pipeline, 2010 51Table 5: Nanotechnology in Drug Delivery, Global, Phase I Clinical Pipeline, 2010 52Table 6: Nanotechnology in Drug Delivery, Global, Preclinical Pipeline, 2010 53Table 7: Nanotechnology in Drug Delivery, Global, Discovery Pipeline, 2010 54Table 8: Abraxis BioScience, Inc., Nano-Enabled Drug Delivery Pipeline Products, 2010 67Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential (From Slideshare) Page 4/7
  • 5. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!Table 9: AlphaRx Corporation, Inc., Nano-enabled Drug Delivery Pipeline Products, 2010 69Table 10: Camurus AB, Inc., Nano-enabled Drug Delivery Pipeline Products, 2010 70Table 11: Eurand, Inc., Nano-enabled Drug Delivery Pipeline Products, 2010 71Table 12: NanoBio Corporation, Inc., Nano-enabled Drug Delivery Pipeline Products, 2010 72Table 13: NanoCarrier, Inc., Nano-enabled Drug Delivery Pipeline Products, 2010 73List of Figures1.2 List of FiguresFigure 1: Nanotechnology in Drug Delivery, Comparison of General and Nano-enabled Drugs, 2010 7Figure 2: Nanotechnology in Drug Delivery, Current Application of Nanotechnology in the Pharmaceutical Industry, 2010 9Figure 3: Nanotechnology in Drug Delivery, Future Application of Nanotechnology in Drug Pharmaceutical Industry, 2010 11Figure 4: Nanotechnology in Drug Delivery, Global, Driver and Restraints, 2010 17Figure 5: Nanotechnology in Drug Delivery, Opportunity and Unmet Needs, 2010 19Figure 6: Nanotechnology in Drug Delivery, Trend Analysis, 2010 40Figure 7: Nanotechnology in Drug Delivery, Challenges Facing Regulators Regarding Nanotechnology 43Figure 8: Nanotechnology in Drug Delivery, Global, Pipeline by Therapy Area (%), 2010 49Figure 9: Nanotechnology in Drug Delivery, Global, Pipeline by Phase (%), 2010 50Figure 10: Nanotechnology in Drug Delivery, Global, M&A Deals by Geography (%), (2006-2010) 55Figure 11: Nanotechnology in Drug Delivery, Global, M&A Deals by Deals Value (%), 2006-2010 56Figure 12: Nanotechnology in Drug Delivery, Global, M&A Deals by Deals Type (%), 2006-2010 57Figure 13: Nanotechnology in Drug Delivery, Global, Licensing Agreements by Years of Consolidation (%), 2006-2010 60Figure 14: Nanotechnology in Drug Delivery, Global, Licensing Agreements by Geography (%), 2006-2010 61Figure 15: Nanotechnology in Drug Delivery, Global, Licensing Agreements by Deals Value (%), 2006-2010 62Figure 16: Nanotechnology in Drug Delivery, Global, Clinical Pipeline by Company, 2010 65Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential (From Slideshare) Page 5/7
  • 6. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93 If you have any questions please visit http://www.reportlinker.com/notify/contact Order Information Please verify that the product information is correct and select the format(s) you require. Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential Product Formats Please select the product formats and the quantity you require. 1 User License--USD 3 500.00 Quantity: _____ Site License--USD 7 000.00 Quantity: _____ Corporate License--USD 10 500.00 Quantity: _____ Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: _____________________________ Last Name: __________________________________ Email Address: __________________________________________________________________________ Job Title: __________________________________________________________________________ Organization: __________________________________________________________________________ Address: __________________________________________________________________________ City: __________________________________________________________________________ Postal / Zip Code: __________________________________________________________________________ Country: __________________________________________________________________________ Phone Number: __________________________________________________________________________ Fax Number: __________________________________________________________________________Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential (From Slideshare) Page 6/7
  • 7. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box. Payment by credit card Card Number: ______________________________________________ Expiry Date __________ / _________ CVV Number _____________________ Card Type (ex: Visa, Amex…) _________________________________ Payment by wire transfer Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189 Payment by check UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE Customer signature:   Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential (From Slideshare) Page 7/7

Related Documents